The growing emphasis on personalized medicine is expected to drive the expansion of the coil transcatheter embolization and occlusion devices market. Personalized medicine tailors healthcare decisions and treatments based on an individual’s genetic makeup, lifestyle, and environment. The rise in personalized medicine is largely due to advancements in genomic sequencing, which have made it more affordable and accessible to customize treatments according to genetic profiles. Coil transcatheter embolization and occlusion devices contribute to the advancement of personalized medicine by enabling precise, patient-specific treatments. Using advanced imaging, these devices are adapted to an individual’s vascular anatomy, allowing for targeted treatment of abnormal blood vessels or tumors while minimizing damage to healthy tissue. For example, in 2022, the Personalized Medicine Coalition reported that 12 new personalized medicines accounted for approximately 34% of all new therapies approved, a notable increase from previous years. As a result, the growing emphasis on personalized medicine is fueling the market for coil transcatheter embolization and occlusion devices.
Leading companies in the coil transcatheter embolization and occlusion devices market are focusing on creating advanced products, such as medical implants, to improve precision, reduce procedure time, and support minimally invasive treatments. These advanced medical implants are long-term devices surgically placed inside the body to replace, support, or enhance biological functions, often incorporating technologies such as sensors, electronics, or drug delivery systems. For instance, in March 2022, Artio Medical Inc., a US-based company, received FDA 510(k) clearance for its Solus Gold Embolization Device. This next-generation device is designed for peripheral vascular occlusion, helping to address the limitations of existing devices, particularly in challenging anatomical cases.
In January 2025, Kaneka Corporation, a Japan-based chemical manufacturer, acquired EndoStream Medical Ltd., a company specializing in coil transcatheter embolization and occlusion devices for brain aneurysm treatment. This acquisition strengthens Kaneka's neurovascular portfolio, particularly by integrating EndoStream's innovative technologies, such as the Nautilus device for wide-neck cerebral aneurysms. Kaneka aims to use this acquisition to accelerate the development and global distribution of advanced coil embolization solutions.
Major players in the coil transcatheter embolization and occlusion devices market are Johnson and Johnson, Abbott Laboratories, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Terumo Medical Corporation, Kaneka Corporation, Cook Medical LLC, Merit Medical Systems Inc., Penumbra Inc., MicroVention Inc., Asahi Intecc Co. Ltd., Balt Extrusion SAS, Phenox GmbH, Acandis GmbH & Co. KG, B. Braun Interventional Systems Inc., EndoShape Inc., Shape Memory Medical Inc., Artio Medical Inc., Medico's Hirata Inc.
North America was the largest region in the coil transcatheter embolization and occlusion devices market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in coil transcatheter embolization and occlusion devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the coil transcatheter embolization and occlusion devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The coil transcatheter embolization and occlusion devices market consists of sales of hydrogel-coated coils, fibered coils, and neurovascular coils. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Leading companies in the coil transcatheter embolization and occlusion devices market are focusing on creating advanced products, such as medical implants, to improve precision, reduce procedure time, and support minimally invasive treatments. These advanced medical implants are long-term devices surgically placed inside the body to replace, support, or enhance biological functions, often incorporating technologies such as sensors, electronics, or drug delivery systems. For instance, in March 2022, Artio Medical Inc., a US-based company, received FDA 510(k) clearance for its Solus Gold Embolization Device. This next-generation device is designed for peripheral vascular occlusion, helping to address the limitations of existing devices, particularly in challenging anatomical cases.
In January 2025, Kaneka Corporation, a Japan-based chemical manufacturer, acquired EndoStream Medical Ltd., a company specializing in coil transcatheter embolization and occlusion devices for brain aneurysm treatment. This acquisition strengthens Kaneka's neurovascular portfolio, particularly by integrating EndoStream's innovative technologies, such as the Nautilus device for wide-neck cerebral aneurysms. Kaneka aims to use this acquisition to accelerate the development and global distribution of advanced coil embolization solutions.
Major players in the coil transcatheter embolization and occlusion devices market are Johnson and Johnson, Abbott Laboratories, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Terumo Medical Corporation, Kaneka Corporation, Cook Medical LLC, Merit Medical Systems Inc., Penumbra Inc., MicroVention Inc., Asahi Intecc Co. Ltd., Balt Extrusion SAS, Phenox GmbH, Acandis GmbH & Co. KG, B. Braun Interventional Systems Inc., EndoShape Inc., Shape Memory Medical Inc., Artio Medical Inc., Medico's Hirata Inc.
North America was the largest region in the coil transcatheter embolization and occlusion devices market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in coil transcatheter embolization and occlusion devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the coil transcatheter embolization and occlusion devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The coil transcatheter embolization and occlusion devices market consists of sales of hydrogel-coated coils, fibered coils, and neurovascular coils. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Coil Transcatheter Embolization And Occlusion Devices Market Characteristics3. Coil Transcatheter Embolization And Occlusion Devices Market Trends And Strategies4. Coil Transcatheter Embolization And Occlusion Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market32. Global Coil Transcatheter Embolization And Occlusion Devices Market Competitive Benchmarking And Dashboard33. Key Mergers And Acquisitions In The Coil Transcatheter Embolization And Occlusion Devices Market34. Recent Developments In The Coil Transcatheter Embolization And Occlusion Devices Market
5. Global Coil Transcatheter Embolization And Occlusion Devices Growth Analysis And Strategic Analysis Framework
6. Coil Transcatheter Embolization And Occlusion Devices Market Segmentation
7. Coil Transcatheter Embolization And Occlusion Devices Market Regional And Country Analysis
8. Asia-Pacific Coil Transcatheter Embolization And Occlusion Devices Market
9. China Coil Transcatheter Embolization And Occlusion Devices Market
10. India Coil Transcatheter Embolization And Occlusion Devices Market
11. Japan Coil Transcatheter Embolization And Occlusion Devices Market
12. Australia Coil Transcatheter Embolization And Occlusion Devices Market
13. Indonesia Coil Transcatheter Embolization And Occlusion Devices Market
14. South Korea Coil Transcatheter Embolization And Occlusion Devices Market
15. Western Europe Coil Transcatheter Embolization And Occlusion Devices Market
16. UK Coil Transcatheter Embolization And Occlusion Devices Market
17. Germany Coil Transcatheter Embolization And Occlusion Devices Market
18. France Coil Transcatheter Embolization And Occlusion Devices Market
19. Italy Coil Transcatheter Embolization And Occlusion Devices Market
20. Spain Coil Transcatheter Embolization And Occlusion Devices Market
21. Eastern Europe Coil Transcatheter Embolization And Occlusion Devices Market
22. Russia Coil Transcatheter Embolization And Occlusion Devices Market
23. North America Coil Transcatheter Embolization And Occlusion Devices Market
24. USA Coil Transcatheter Embolization And Occlusion Devices Market
25. Canada Coil Transcatheter Embolization And Occlusion Devices Market
26. South America Coil Transcatheter Embolization And Occlusion Devices Market
27. Brazil Coil Transcatheter Embolization And Occlusion Devices Market
28. Middle East Coil Transcatheter Embolization And Occlusion Devices Market
29. Africa Coil Transcatheter Embolization And Occlusion Devices Market
30. Coil Transcatheter Embolization And Occlusion Devices Market Competitive Landscape And Company Profiles
31. Coil Transcatheter Embolization And Occlusion Devices Market Other Major And Innovative Companies
35. Coil Transcatheter Embolization And Occlusion Devices Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Coil Transcatheter Embolization And Occlusion Devices Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on coil transcatheter embolization and occlusion devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for coil transcatheter embolization and occlusion devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The coil transcatheter embolization and occlusion devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Product Type: Detachable Coils; Pushable Coils; Other Product Types2) By Procedure Type: Hemorrhage Control; Vascular Occlusion; Aneurysm Treatment; Tumor Embolization; Other Procedure Types
3) By Material: Platinum Or Platinum Alloy; Nickel Titanium; Stainless Steel; Other Materials
4) By End-User: Hospitals; Ambulatory Surgical Centers (Ascs); Specialty Clinics; Research And Academic Institutes
Subsegments
1) By Detachable Coils: Electrically Detachable Coils; Mechanically Detachable Coils2) By Pushable Coils: Fibered Coils; Non-Fibered Coils
3) By Other Product Types: Framing Coils; Filling Coils; Liquid Embolic Agents
Key Companies Profiled: Johnson and Johnson; Abbott Laboratories; Medtronic plc; Stryker Corporation; Boston Scientific Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Johnson and Johnson
- Abbott Laboratories
- Medtronic plc
- Stryker Corporation
- Boston Scientific Corporation
- Terumo Medical Corporation
- Kaneka Corporation
- Cook Medical LLC
- Merit Medical Systems Inc.
- Penumbra Inc.
- MicroVention Inc.
- Asahi Intecc Co. Ltd.
- Balt Extrusion SAS
- Phenox GmbH
- Acandis GmbH & Co. KG
- B. Braun Interventional Systems Inc.
- EndoShape Inc.
- Shape Memory Medical Inc.
- Artio Medical Inc.
- Medico's Hirata Inc.